Try our mobile app

Dealing in securities by executive directors, prescribed officers and company secretary

Published: 2023-11-30 17:45:24 ET
<<<  go to JSE:HAR company page
Harmony Gold Mining Company Ltd
Registration number: 1950/038232/06
Incorporated in the Republic of South Africa
ISIN: ZAE000015228
JSE share code: HAR
(“Harmony” or “the company”)

In compliance with paragraphs 3.63 to 3.74 of the JSE Listings
Requirements, the following information is disclosed:

DEALING IN SECURITIES BY EXECUTIVE DIRECTORS, PRESCRIBED OFFICERS
AND COMPANY SECRETARY

Johannesburg, 30 November 2023. In line with the provisions of
the 2018 Harmony Deferred Share Plan, executive directors and
prescribed officers of Harmony were awarded deferred shares on 18
September 2023 based on the 5-day volume weighted average price of
R83.09 per ordinary share and accepted these awards on 29 November
2023. In addition, in compliance with paragraphs 3.63 to 3.74 of the
JSE   Listings    Requirements,   dealing   in    securities   by  a
prescribed officer is disclosed.

The following transactions are disclosed in relation to the
deferred share awards:


1.   Name of director:          PW Steenkamp (Chief Executive
                                Officer)

     Nature of transaction:     Off market award of deferred shares

     Periods of vesting:        Deferred shares vest in five equal
                                tranches over a five year period

     Class of securities:       Deferred ordinary shares

     Number of deferred         107 359
     shares awarded:

     Total value of shares      R8 920 459.31
     awarded:

     Nature and extent of       Direct beneficial
     director’s interest:




                                                                      1
2.   Name of director:        B Lekubo (Financial Director)

     Nature of transaction:   Off market award of deferred shares

     Periods of vesting:      Deferred shares vest in five equal
                              tranches over a five year period

     Class of securities:     Deferred ordinary shares

     Number of deferred       59 022
     shares awarded:

     Total value of shares    R4 904 137.98
     awarded:

     Nature and extent of     Direct beneficial
     director’s interest:



3.   Name of director:        HE Mashego (Executive Director)

     Nature of transaction:   Off market award of deferred shares

     Periods of vesting:      Deferred shares vest in five equal
                              tranches over a five year period

     Class of securities:     Deferred ordinary shares

     Number of deferred       52 657
     shares awarded:

     Total value of shares    R4 375 270.13
     awarded:

     Nature and extent of     Direct beneficial
     director’s interest:




                                                                    2
4.   Name of prescribed        AZ Buthelezi
     officer:
     Nature of transaction:    Off market award of deferred shares

     Periods of vesting:       Deferred shares vest in five equal
                               tranches over a five year period

     Class of securities:      Deferred ordinary shares

     Number of deferred shares 49 559
     awarded:
     Total value of shares     R4 117 857.31
     awarded:

     Nature and extent of      Direct beneficial
     prescribed officer’s
     interest:



5.   Name of prescribed        BB Nel
     officer:
     Nature of transaction:    Off market award of deferred shares

     Periods of vesting:       Deferred shares vest in five equal
                               tranches over a five year period

     Class of securities:      Deferred ordinary shares

     Number of deferred        66 512
     shares awarded:
     Total value of shares     R5 526 482.08
     awarded:

     Nature and extent of      Direct beneficial
     prescribed officer’s
     interest:




                                                                     3
6.   Name of prescribed        MP van der Walt
     officer:
     Nature of transaction:    Off market award of deferred shares

     Periods of vesting:       Deferred shares vest in five equal
                               tranches over a five year period

     Class of securities:      Deferred ordinary shares

     Number of deferred shares 49 559
     awarded:
     Total value of shares     R4 117 857.31
     awarded:

     Nature and extent of      Direct beneficial
     prescribed officer’s
     interest:

     Date of transaction       30 November 2023

     Type of transaction:      On-market sale of ordinary shares

     Class of securities:      Ordinary shares

     Number of shares:         49 000

     Volume Weighted Average   R116.5766
     price per share:
     Highest sale price:       R117.65

     Lowest sale price:        R116.25

     Total value of shares:    R5 712 253

     Nature and extent of      Direct beneficial
     interest



7.   Name of prescribed        JJ van Heerden
     officer:
     Nature of transaction:    Off market award of deferred shares

     Periods of vesting:       Deferred shares vest in five equal
                               tranches over a five year period

     Class of securities:      Deferred ordinary shares

     Number of deferred        66 151
     shares awarded:


                                                                     4
        Total value of shares    R5 496 486.59
        awarded:

        Nature and extent of     Direct beneficial
        prescribed officer’s
        interest:



8.      Name of company          SS Mohatla
        secretary:
        Nature of transaction:   Off market award of deferred shares

        Periods of vesting:      Deferred shares vest in three equal
                                 tranches over a three period

        Class of securities:     Deferred ordinary shares

        Number of deferred       19 737
        shares awarded:
        Total value of shares    R1 639 947.33
        awarded:

        Nature and extent of     Direct beneficial
        company secretary’s
        interest:


Prior clearance was obtained in respect of the above dealings by the
executive directors, prescribed officers and company secretary.

Ends.

For more details contact:


Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120


Johannesburg, South Africa
30 November 2023


Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited




                                                                       5